Orna
1 known investors
Orna Therapeutics develops RNA and lipid nanoparticle (LNP) based therapies for treating diseases including oncology and cell therapy applications. The company leverages proprietary drug development expertise in oRNA and LNP technology platforms.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
JB
Joe BolenChief Executive Officer
JB
Joe Bolen, Ph.D.Chief Executive Officer
HD
Hope D'Oyley-Gay, JDChief Legal Officer
CL
Ciaran Lawlor, Ph.D.Chief Operating Officer
FN
Frank Neumann, M.D., Ph.D.Chief Medical Officer
SS
Siva SakhamuriChief Technology Officer
BS
Brian ShusterChief Business Officer
Investors · 1
In the news
- Biotech Startup M&A Is Reliably Delivering Some Big Exitsnews.crunchbase.com · 2026
- Orna Therapeutics Raises $221M in Series B Financingfinsmes.com · 2022
- Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic - Orna Therapeuticsornatx.com · 2022
- Orna Raises $1 Million In Seed Round | The SaaS Newsthesaasnews.com · 2022
- Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies - BioSpacebiospace.com · 2021
- Orna Raises $80 Million to Develop a New Class of Engineered RNA Therapies - Global Genesglobalgenes.org · 2021